Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

266 Results

Guidelines and Advice

Radiopharmaceuticals in the Palliation of Painful Bone Metastases

Status: Archived
ID: 14-1

Jan 2015

Guidelines and Advice

Sunitinib Malate for Gastrointestinal Stromal Tumour (GIST) in Imatinib Mesylate Resistant Patients

Status: Archived
ID: 11-8
Version: 2

Oct 2015

Guidelines and Advice

Implementation Strategy for Radiation Therapy Safety Straps

Status: Current
ID: GL-C50-22

Oct 2015

Guidelines and Advice

Recommendation Report: Entry and Transfer of Care Criteria for Lung Diagnostic Assessment Programs (DAPs) in Ontario

Status: Education and Information
ID: GL-C50-23-V1
Version: 2

Dec 2015

Drug Safety & Advice

Reference List for Appendix 2 - Extravasation Potential of Various Chemotherapy/Supportive Agents

Jul 2015

Guidelines and Advice

Preoperative or Postoperative Therapy for the Management of Patients with Stage II or III Rectal Cancer

Status: In-Review
ID: 2-4
Version: 3

Mar 2019

Statistical Reports

Cancer in the Métis People of Ontario: Risk Factors and Screening Behaviours

Jul 2015

Statistical Reports

Cancer Risk Factors in Ontario: Healthy Weights, Healthy Eating and Active Living

Mar 2015

Guidelines and Advice

ColonCancerCheck Recommendations for Post-Polypectomy Surveillance

Status: Current

Mar 2019

Guidelines and Advice

Cancer Care Ontario’s Focus on Take-Home Cancer Drugs and Community Practice

Status: Current
ID: GL-C50-17

Jan 2015

Guidelines and Advice

Clinical Verification of Cancer Drug Prescriptions Checklist: Cancer Centres and Specialty Pharmacies

Status: Current
ID: GL-C50-18

Jan 2015

Guidelines and Advice

2019 Antiemetic Recommendations for Chemotherapy-Induced Nausea and Vomiting: A Clinical Practice Guideline

Status: Current
ID: GL-C50-09

Jun 2019

Pages